CytoSorbents Corporation (CTSO)

[KCRoyal2004]

I emailed Dr. Ronco about this, even suggesting that he representing both companies suggested a conflict of interest. In addition, I asked him if he thought that the HA380 was superior to Cytosorb since this was his most recent paper regarding extracorporeal Therapies.

His response:

"My intent is not commercial. I think both devices do what i think is
useful"

Claudio Ronco, MD

Full Professor of Nephrology
Università degli Studi di Padova

Director
Dep. Nephrology Dialysis & Transplantation
International Renal Research Institute (IRRIV)
San Bortolo Hospital
Viale Rodolfi, 37
36100 Vicenza, Italy
Tel. [phone]
Fax. [phone]